Ropes & Gray Advises on Sale of WellSky International to System C Healthcare
Ropes & Gray has advised WellSky Corporation – a portfolio company of TPG Capital and Leonard Green & Partners – on the sale of WellSky International to System C Healthcare, a provider of information technology implementation software and services to the health sector – and portfolio company of CVC Capital Partners.
Headquartered in Essex, UK, WellSky International is a UK-based medicines management company best known for clinical software in Pharmacy and Electronic Prescribing and Medicines Administration (EPMA). Its product portfolio encompasses critical care, emergency care, theatres, controlled drugs and mobile solutions for provision of bedside closed loop solutions and are used by a large number of NHS Trusts and Health Boards across England, Scotland, Wales and Northern Ireland, in addition to a number of international clients.
Its chemotherapy software is widely used internationally, particularly in Benelux and Scandinavia. Its pharmacy solutions also have an international footprint, with a large-scale solution covering some six million people deployed across 45 hospitals and 80 clinics in Western Cape, South Africa.
The Ropes & Gray team was led by private equity transactions associate Matthew Martindale working alongside counsel Victoria McGrath and partner John Newton, all based in London. Other members of the team included: privacy, data protection and cybersecurity partner Rohan Massey and counsel Clare Sellars (London); tax partner Andrew Howard (London); executive compensation & employee benefits partner Danna Kivell (New York); private equity real estate associate Nick Steynberg (London), litigation & enforcement counsel Sean Seelinger (London) and associate Brendan Kearney (Washington DC) and trainees Chad Parkinson, Emilio Fabrizi and William Radcliffe (London).
Ropes & Gray is recognised as one of the world’s leading health care and life sciences industry law firms. The firm won nearly every health care-focused legal industry award in 2020, including the FT’s Innovative Lawyers 2020 top honour for guiding clients through the COVID-19 pandemic. Other awards included being named Law Firm of the Year for Health Care by The American Lawyer, U.S. News - Best Lawyers, and Law360 (an award the firm has won for the second year in a row). Please click here for examples of the firm’s work in this area, alongside business and legal trends that the team has seen within the health care and life sciences industries in 2020.
In April this year, the firm strengthened its industry-leading life sciences practice with the appointment of Dr Lincoln Tsang, one of world’s leading lawyers in the field, as a partner and head of its European Life Sciences practice, based in London. Further details can be found here.